Core needle biopsy more sensitive for cervical lymphadenopathy examination

This article originally appeared here.
Share this content:
Core Needle Biopsy Helpful With Cervical Lymphadenopathy
Core Needle Biopsy Helpful With Cervical Lymphadenopathy

(HealthDay News) -- Core needle biopsy (CNB) is a more sensitive tool than fine-needle aspiration cytology (FNAC) for cervical lymphadenopathy evaluation, according to a study published in the February issue of Head & Neck.

Yoon-Jong Ryu, M.D., from Seoul National University College of Medicine in South Korea, and colleagues evaluated the value of CNB compared to FNAC in 208 consecutive patients with cervical lymphadenopathy.

The researchers found that the sensitivity and negative predictive value for critical disease (lymphoma, carcinoma, and tuberculosis) were significantly higher with CNB (P = 0.006 and 0.001, respectively), compared to FNAC. The sensitivity of CNB was significantly higher (P = 0.009) for the diagnosis of lymphoma. With CNB the rate of open biopsy for confirmative diagnosis was significantly lower (P = 0.014).

"CNB is beneficial for initial examination in cervical lymphadenopathy and showed higher sensitivity and negative predictive value than FNAC," the authors write. "It is especially useful for screening for lymphoma."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs